Champions Oncology: Feeling Met Like the Big Apple Champions Oncology, Inc. (NASDAQ: CSBR) has really stepped into the spotlight recently, hitting a fresh 52-week high at $9.94. With a market cap in the ballpark of $133 million and annual revenue of around $54 million, this biotech wonder is trading above its InvestingPro Fair Value. Tech […]
Viad Corp’s stock hitting a fresh 52-week high is the talk of the town here. We’re seeing the shares waltz up to $45.71, a cool 39.07% jump in the past year. Investors seem to be betting big on Viad, their faith bolstered by the company’s strategic moves and sterling financial performance. Viad’s Financial Performance doesn’t […]
